InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Pam2CSK4 | Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in ... | 2021 | J Med Chem. | Facchini F.A. et al. | DOI: 10.1021/acs.jmedchem.1c00896 |
| ISD | Brucella spp. Omp25 Promotes Proteasome-Mediated cGAS Degradation to Attenuat... | 2021 | Front Microbiol. | Li R. et al. | DOI: 10.3389/fmicb.2021.702881 |
| 2'3'-cGAMP | Brucella spp. Omp25 Promotes Proteasome-Mediated cGAS Degradation to Attenuat... | 2021 | Front Microbiol. | Li R. et al. | DOI: 10.3389/fmicb.2021.702881 |
| PlasmoTest™ - Mycoplasma Detection Kit | Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR ... | 2021 | Cancer Immunol Res. | Xia L. et al. | DOI: 10.1158/2326-6066.CIR-20-0405 |
| Puromycin | Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR ... | 2021 | Cancer Immunol Res. | Xia L. et al. | DOI: 10.1158/2326-6066.CIR-20-0405 |
| Amlexanox | STING agonist-based treatment promotes vascular normalization and tertiary ly... | 2021 | J Immunother Cancer | Chelvanambi M. et al. | DOI: 10.1136/jitc-2020-001906 |
| Amlexanox | Annexin-A1 promotes RIG-I-dependent signaling and apoptosis via regulation of... | 2020 | Cell Death Dis. | Yap G.L.R. et al. | DOI: 10.1038/s41419-020-2625-7 |
| Pepinh-MYD | Integration of T helper and BCR signals governs enhanced plasma cell differen... | 2021 | Cell Rep. | Szodoray P. et al. | DOI: 10.1016/j.celrep.2021.109525 |
| ODN 2006 (ODN 7909) | Integration of T helper and BCR signals governs enhanced plasma cell differen... | 2021 | Cell Rep. | Szodoray P. et al. | DOI: 10.1016/j.celrep.2021.109525 |
| Human TLR1-9 Agonist kit | Integration of T helper and BCR signals governs enhanced plasma cell differen... | 2021 | Cell Rep. | Szodoray P. et al. | DOI: 10.1016/j.celrep.2021.109525 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Role of ascorbic acid in the regulation of epigenetic processes induced by Po... | 2021 | Histochem Cell Biol | Pizzicannella J. et al. | DOI: 10.1007/s00418-021-02014-8 |
| Anti-PD-L1 (Atezolizumab biosimilar - IgG1 (N298A) isotype) | Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inh... | 2021 | J Immunother Cancer | Hamdan F. et al. | DOI: 10.1136/jitc-2021-003000 |
| Anti-PD-L1 (Atezolizumab biosimilar - IgG1 isotype) | Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inh... | 2021 | J Immunother Cancer | Hamdan F. et al. | DOI: 10.1136/jitc-2021-003000 |
| Pam3CSK4 | Inflammasome-induced extracellular vesicles harbour distinct RNA signatures a... | 2021 | J Extracell Vesicles | Budden C.F. et al. | DOI: 10.1002/jev2.12127 |
| Imiquimod (R837) | Inflammasome-induced extracellular vesicles harbour distinct RNA signatures a... | 2021 | J Extracell Vesicles | Budden C.F. et al. | DOI: 10.1002/jev2.12127 |
| R848 (Resiquimod) | Inflammasome-induced extracellular vesicles harbour distinct RNA signatures a... | 2021 | J Extracell Vesicles | Budden C.F. et al. | DOI: 10.1002/jev2.12127 |
| Alhydrogel® adjuvant 2% | Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+... | 2021 | Vaccine | Sun J. et al. | OI: 10.1016/j.vaccine.2021.07.036 |
| Adju-Phos® adjuvant | Development of combination adjuvant for efficient T cell and antibody respons... | 2021 | PLoS One. | Haseda Y. et al. | DOI: 10.1371/journal.pone.0254628 |
| Alhydrogel® adjuvant 2% | Development of combination adjuvant for efficient T cell and antibody respons... | 2021 | PLoS One. | Haseda Y. et al. | DOI: 10.1371/journal.pone.0254628 |
| EIF2AK2 | Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote vir... | 2021 | Cell Rep. | Zaman A. et al. | DOI: 10.1016/j.celrep.2021.109491 |